| abstract |
The present invention relates to new 2-(arylalkyloxymethyl)morpholine derivatives, the preparation thereof and their application as drugs which are useful in the treatment of disorders of the central nervous system. The 2-(arylalkyloxymethyl)morpholine derivatives according to the invention correspond to the general formula (I): <IMAGE> (I) in which: Ar denotes an aromatic group and more especially the following radicals: <IMAGE> +TR <IMAGE> in the case where Ar denotes a phenyl radical and R denotes a hydrogen atom, an alkyl, alkoxy or halogen group, a trifluoromethyl radical, a nitro or amino group, a hydroxy group or an arylalkyloxy group. |